Evaluation of the Safety and Effectiveness of Transjugular Implantation of Leadless Pacemakers

INTERVENTION: Group with femoral vein implantation (control group):Leadless pacemaker implanted via femoral vein;Internal jugular vein implantation group (intervention group):Transjugular vein implantation of a leadless pacemaker; CONDITION: Patients with indications for leadless pacemaker implantation PRIMARY OUTCOME: The success rate of pacemaker implantation;Procedural complications;The eletrical paramaters of pacemaker during follow‐up; SECONDARY OUTCOME: The times of re‐location for pacemaker;X‐ray exposure time;Postoperative bed rest duration;The location of pacemaker implantation;The duration of first successful trans tricuspid valve;The dose of contrast;The duration for pacemaker deployment;The ength of stay;Patient comfort score;Procedural time;Adverse events; INCLUSION CRITERIA: 1. Patients with indications for leadless pacemaker implantation: (1) Patients with recurrent pacemaker system infection or infective endocarditis; (2) Patients with end‐stage renal disease or on hemodialysis; (3) Patients with other clinical conditions or comorbidities that make traditional pacemaker implantation particularly difficult or prone to complications; (4) Patients at high risk of pacemaker system infection; (5) Patients at high risk of lead‐related complications; (6) Patients with permanent or persistent atrial fibrillation and a low expected ventricular pacing percentage; (7) Patients with intermittent second‐degree and high‐degree atrioventricular block and a low expected ventricular pacing percentage; (8) Patients with sinus arrest or sinoatrial block and a low expected ventricular pacing percentage; (9) Patients with second‐degree or higher atrioventricular block, a high expected ventricular pacing percent